| __timestamp | Alkermes plc | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7753000 | 13673000 |
| Thursday, January 1, 2015 | 4019000 | 14358000 |
| Friday, January 1, 2016 | 2301000 | 12203000 |
| Sunday, January 1, 2017 | 7232000 | 18125000 |
| Monday, January 1, 2018 | 68895000 | 17071000 |
| Tuesday, January 1, 2019 | 52816000 | 20018000 |
| Wednesday, January 1, 2020 | 1946000 | 32788000 |
| Friday, January 1, 2021 | 1020000 | 44966000 |
| Saturday, January 1, 2022 | 393842000 | 311681000 |
| Sunday, January 1, 2023 | 270806000 | 77707000 |
Unlocking the unknown
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Lantheus Holdings, Inc. and Alkermes plc have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Alkermes plc's R&D expenses surged by over 3,400%, peaking in 2022 with a staggering 394 million dollars. This reflects a strategic pivot towards aggressive innovation. In contrast, Lantheus Holdings, Inc. maintained a more consistent growth, with a notable 227% increase in R&D spending over the same period, reaching its zenith in 2022 with 312 million dollars. This steady approach underscores a commitment to sustainable development. The data reveals a fascinating narrative of two companies navigating the complexities of pharmaceutical advancements, each with its unique approach to fueling future breakthroughs.
Eli Lilly and Company vs Lantheus Holdings, Inc.: Strategic Focus on R&D Spending
Eli Lilly and Company or Alkermes plc: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Lantheus Holdings, Inc.
Research and Development: Comparing Key Metrics for Sanofi and Lantheus Holdings, Inc.
Research and Development: Comparing Key Metrics for BeiGene, Ltd. and Alkermes plc
Research and Development Investment: Summit Therapeutics Inc. vs Alkermes plc
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Lantheus Holdings, Inc.
Blueprint Medicines Corporation or Lantheus Holdings, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Blueprint Medicines Corporation and Alkermes plc
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs Supernus Pharmaceuticals, Inc.
Research and Development Investment: Alkermes plc vs Verona Pharma plc
Alkermes plc vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending